SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-058291
Filing Date
2023-03-02
Accepted
2023-03-02 16:54:06
Documents
12
Period of Report
2023-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d448815d8k.htm   iXBRL 8-K 22683
  Complete submission text file 0001193125-23-058291.txt   147813

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA svra-20230228.xsd EX-101.SCH 2864
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20230228_lab.xml EX-101.LAB 18756
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20230228_pre.xml EX-101.PRE 11719
6 EXTRACTED XBRL INSTANCE DOCUMENT d448815d8k_htm.xml XML 3510
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 23699955
SIC: 2834 Pharmaceutical Preparations